Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Cancer: Repositioned to kill stem cells.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Subject Terms:
- Abstract:
The article discusses the treatment of chronic myeloid leukaemia (CML) through targeting drug-resistant leukaemic stem cells (LSCs), referencing a study coauthored by the scientist S. Prost which appears within the issue. An overview of the development of tyrosine kinase inhibitors (TKIs) is provided.
No Comments.